Gsk Share Discussion Threads

[kev0856153] 05/3/2021 15:40

and again whipping the FTSE's ass.

[roybel] 05/3/2021 15:33

Thanks Monty,very interesting and filled in a lot of the blanks.
Could be time to free-up some notes.

[montyhedge] 05/3/2021 14:09

Its GSK way into a vaccine, some analyst think Curvac could have a 64 billion euro market cap in the future, I think GSK have a 9% stake, that would be a tasty 5.7 billion euro bonus for GSK. Could Walsmley have backed a winner here. Interesting article.

[montyhedge] 05/3/2021 14:04

Perhaps some good new, all being well should have a run up back to 1350p.

[spud] 05/3/2021 10:08

First EW needs to go as she's clearly out of her depth. Only then can the Company can take stock and reorganise. spud

[roybel] 05/3/2021 10:05

Will we get a prospectus for the new companies ?

[montyhedge] 05/3/2021 09:36

I thought something this big, dividend cut, the split should go to shareholder vote, we own the company not directors.

[buywell3] 05/3/2021 08:55

Seems like a pattern starting to emerge of weakness in the NASDAQ price after UK close
Ditto AZN and other UK stocks


Inflationary pressures and rate rises causing the Yanks to think harder than for some time about where to put their lolly

[montyhedge] 05/3/2021 08:54

Agree with that, she wants to go down has this split is her legacy.

[spud] 05/3/2021 08:50

EW - Definitely a toxic drag on the Company and the sooner she is ousted the better imo.spud

[montyhedge] 05/3/2021 08:49

Shareholders own the company directors manage the company, I'm amazed shareholders just rolling over and let Walmsley do what she wants. Cutting the dividend is a cardinal sin for income seekers.

[wormhasturned] 05/3/2021 08:37

To appoint her from within was a huge mistake, that is history, but watching this company being suffocated before being consumed is an absolute shocker. It is a wanton act of corporate murder!

[montyhedge] 05/3/2021 08:17

She wants to cut the dividend which upsets 99% of investors I would say.

[wormhasturned] 05/3/2021 08:12

Does the fool leading this company not listen to her largest shareholders, because if she did she might be aware that they disapprove of value destruction. I am sure that they do not solely think of the dividend contribution, but more the cost of that dividend to the stability of the company. Why she was appointed to the role of CEO is beyond, and it is clear she is a woman with a complete lack of empathy as she has not acknowledged that GSK will cease to exist post the separation. For a company that has amalgamated from the the Wellcome, SmithKline Beecham and Glaxo Organisation organisations, it is shocking to see the failures that management has achieved in terms of value to the company that resulted. Splitting may be obvious but at what cost!

[montyhedge] 04/3/2021 16:25

Beating Astra in percentage terms today.

[careful] 04/3/2021 16:00

ulvr does better in weaker markets, risk off.
solid.

[kev0856153] 04/3/2021 15:50

ULVR is also up 1.6%

[montyhedge] 04/3/2021 15:46

If it closes above 1225p that's strong, if not may drift back tomorrow.

[supermarky] 04/3/2021 15:43

Hopefully today will end strong blue and above the recent range

[montyhedge] 04/3/2021 15:28

Good run today.

[montyhedge] 04/3/2021 15:20

I wish, my dividend reinvestment plan it would work wonders.

[eurofox] 04/3/2021 15:17

who is still waiting for 1125?

[tradermichael] 04/3/2021 15:00

London, 15 January 2021 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that it has temporarily paused the launch of its generic version of GlaxoSmithKline̵7;s Advair Diskus®

Technicality with change of packaging: Hikma has submitted to the US FDA an amendment to its application. The amendment reflects enhanced packaging controls to meet new industry standards adopted since the initial submission of its ANDA application.